Chemical Papers Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC–MS characterization, and In-vitro safety evaluation.  76:6415-6426. 2022

publisher

• Springer Science and Business Media LLC  Publisher

Identity

International Standard Serial Number (ISSN)

• 0366-6352
• 2585-7290